NCT04776395 2026-04-17Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple MyelomaEmory UniversityPhase 2 Recruiting68 enrolled
NCT06179888 2026-04-13Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple MyelomaNational Cancer Institute (NCI)Phase 2 Recruiting78 enrolled